Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

JUBILANT PHARMOVA LTD.

NSE : JUBLPHARMABSE : 530019ISIN CODE : INE700A01033Industry : Pharmaceuticals & DrugsHouse : Jubilant Bhartia

BSE1234.9034.4 (+2.87 %)

PREV CLOSE ( ) 1200.50

OPEN PRICE ( ) 1200.65

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 14944

TODAY'S LOW / HIGH ( )1194.05 1239.00

52 WK LOW / HIGH ( )701.4 1309

NSE1232.0031.2 (+2.6 %)

PREV CLOSE( ) 1200.80

OPEN PRICE ( ) 1205.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1232.00 (58)

VOLUME 545057

TODAY'S LOW / HIGH( ) 1194.00 1239.00

52 WK LOW / HIGH ( )701.8 1309.9

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 21-06 1978

Management Info

Shyam S Bhartia - Chairman Priyavrat Bhartia - Managing Director

Registered Office

Address Bhartiagram ,Jyotiba Phoolay Nagar, ,
Gajraula,
Uttar Pradesh-244223

Phone 05924-267437

Email invstors@jubl.com

Website www.jubilantpharmova.com

Registrars Details

Alankit Assignments Ltd.

205-208 , Anarkali Complex,Jhandewala Extension,,New Delhi

Listing : BSE, NSE

NEWS

13Jun Jubilant Pharmova gets nod to sell, tr
Jubilant Pharmova has received approval for sale and transfer of the act..

20Mar Jubilant Pharmova’s arm inks Sharehold
Jubilant Pharmova’s step down subsidiary -- Jubilant Biosys Innovative R..

13Mar Jubilant Pharmova's arm gets EIR with
Jubilant Pharmova’s subsidiary -- Jubilant Cadista Pharmaceuticals Inc.,..

13Mar Jubilant Pharmova trades higher on the
Jubilant Pharmova is currently trading at Rs. 867.05, up by 1.80 points..

27Jan Jubilant Pharmova’s arm voluntary pays
Jubilant Pharmova’s step down subsidiary -- Jubilant Pharma Holdings Inc..

Financials

Rs. in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	136	192
Gross Profit	235	376
Operating Profit	439	1317
Net Sales	2173	7457

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Torrent Pharma (BSE) 3521.85 (0.50%)	M.Cap ( in Cr)119195.41
Mankind Pharma (BSE) 2652.95 (0.47%)	M.Cap ( in Cr)109494.87
Albert David (BSE) 932.95 (0.95%)	M.Cap ( in Cr)532.45
Aarti Drugs (BSE) 522.65 (1.34%)	M.Cap ( in Cr)4770.23
Laurus Labs (BSE) 826.70 (0.63%)	M.Cap ( in Cr)44612.50

Shareholding Pattern

	PROMOTERS	50.68%
	NON-INSTITUTION	25.06%
	MUTUAL FUNDS/UTI	3.66%
	FI/BANKS/INSURANCE	1.36%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Kotak Healthcare Fu...	3.74
Kotak Special Oppor...	3.72
Kotak Consumption F...	2.55
Kotak MNC Fund-Reg(G)	1.92
HDFC Pharma and Hea...	1.75
Bandhan Innovation ...	1.59
Bajaj Finserv Healt...	1.27

Risk Disclosures on Derivatives

Smart Quotes

JUBILANT PHARMOVA LTD.